WellCell Holdings Co., Limited announced a plan to subdivide every existing share with a par value of HK$0.005 into four shares of HK$0.00125 each.

The transaction will keep the authorised share capital unchanged at HK$10.00 million, but will expand the authorised share count from 2 billion to 8 billion shares. Issued shares will rise from 1 billion to 4 billion, assuming no further issuance or repurchase before the effective date.

Management estimates that, based on the 25 March 2026 closing price of HK$17.99 per share, the market value of one board lot (currently 800 shares) would fall from HK$14,392 to about HK$3,598 after the split, potentially lowering the investment threshold and improving liquidity. No odd lots or fractional shares will be created.

Key conditions include: 1. Shareholder approval at an extraordinary general meeting scheduled for 17 April 2026. 2. Listing approval from the Stock Exchange of Hong Kong. 3. Completion of all procedural requirements under Cayman Islands law and Listing Rules.

If approved, the split will take effect on 21 April 2026. Trading in subdivided shares will begin the same day, with parallel trading between old and new certificates from 6 May to 27 May 2026. Free exchange of share certificates will run from 21 April to 29 May 2026.

The board states that the subdivision will not affect shareholders’ proportional interests, the group’s assets or its financial position, and confirms that no fund-raising or further corporate actions that could offset the split are planned within the next 12 months.

Shareholders are advised to note that the proposal remains subject to the stated conditions and may not proceed if any are not met.